Gene · 599
Papers4,142
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,142
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The roles of non-coding RNAs (ncRNAs) in the function of leukemic stem cells (LSCs): a comprehensive review. | Discov Oncol | 2025 | 40853607 | PubTator, text mining | PubMed |
| Research and development prospects of TRIM65. | J Cancer Res Clin Oncol | 2025 | 40844633 | PubTator, text mining | PubMed |
| Cul5Wsb2 uses BCL2 proteins as co-receptors to target Bim for degradation. | bioRxiv | 2025 | 40832228 | PubTator, text mining | PubMed |
| The ATF4-glutamine axis: a central node in cancer metabolism, stress adaptation, and therapeutic targeting. | Cell Death Discov | 2025 | 40830338 | PubTator, text mining | PubMed |
| HCQ reverses the immune imbalance related to severe infections following chemotherapy of acute myeloid leukemia and exhibits inhibitory effects on inflammatory cytokine storms. | Clin Exp Med | 2025 | 40815351 | PubTator, text mining | PubMed |
| Synergistic strategies in photodynamic combination therapy for cancer: mechanisms, nanotechnology, and clinical translation. | Front Oncol | 2025 | 40809017 | PubTator, text mining | PubMed |
| Harnessing PUMA's lethal potential: BCL-2 family dynamics and novel strategies to combat cancer recurrence. | Cancer Treat Res Commun | 2025 | 40780064 | PubTator, text mining | PubMed |
| Persistent accumulation of therapy-induced senescent cells: an obstacle to long-term cancer treatment efficacy. | Int J Oral Sci | 2025 | 40750580 | PubTator, text mining | PubMed |
| De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. | Nat Commun | 2025 | 40738904 | PubTator, text mining | PubMed |
| Genetic modulation of lncPSMB1 confers non-syndromic cleft lip with or without cleft palate susceptibility by promoting cell apoptosis. | Commun Biol | 2025 | 40730884 | PubTator, text mining | PubMed |
| Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo. | Cell | 2025 | 40645177 | PubTator, text mining | PubMed |
| Variable roles of miRNA- and apoptosis-linked genes in invasive breast cancer: expression patterns, clinicopathological associations, and prognostic significance. | Mol Biol Rep | 2025 | 40643805 | PubTator, text mining | PubMed |
| Augmenting the Anti-Leukemic Activity of the BCL-2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL-2/HDAC1 and Dual BCL-2/HDAC6 Inhibitors. | Drug Dev Res | 2025 | 40370107 | PubTator, text mining | PubMed |
| Integration of mitochondrial gene expression and immune landscape in acute kidney injury prediction. | Ren Fail | 2025 | 40369940 | PubTator, text mining | PubMed |
| In Silico Molecular Docking of 2-Hydroxyanthraquinone-Substituted Spiro-/Ansa Cyclotriphosphazenes: Targeting Apoptosis via Heat Shock Protein Modulation in Breast and Colon Cancer Cells. | Biotechnol Appl Biochem | 2025 | 40296721 | PubTator, text mining | PubMed |
| Impact of different chemical debridement agents on early cellular responses to titanium dental implants: A transcriptome-based in vitro study on peri-implant tissue regeneration. | Colloids Surf B Biointerfaces | 2025 | 40288111 | PubTator, text mining | PubMed |
| Sp4/HD11 and Sp1/HAT-p300 complexes induce apoptotic cell death in CuCl2-treated neurons by modulating histone acetylation on BCL-W and BAX promoters. | Neurochem Int | 2025 | 40185277 | PubTator, text mining | PubMed |
| Detection of mRNA Transcript Variants. | Genes (Basel) | 2025 | 40149494 | PubTator, text mining | PubMed |
| Pharmacokinetics and Safety of Navitoclax in Hepatic Impairment. | Clin Pharmacokinet | 2025 | 40146460 | PubTator, text mining | PubMed |
| Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer. | Neoplasia | 2025 | 39999714 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/599/papers?page=3